NHS patients may be denied new prostate cancer drug
Best Medical Cover
The National Institute for Health and Clinical Excellence (NICE) says that abiraterone in combination with prednisone or prednisolone is not recommended for men with prostate cancer that has spread following chemotherapy and cannot be operated upon.
Zytiga cost too high, says NICE
NICE draft "no" for Zytiga
Charities condemn 'no' decision on prostate drug